Published in Hospital Business Week, March 25th, 2007
This trend article about University of New Mexico, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Scientists discuss in "Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review" new findings in life sciences. "Recombinant factor VIIa (rFVIIa) has been used in haemophilia bleeding since its introduction in 1996. It has been found to be safe and effective in the majority of patients with haemophilia who have developed inhibitors," researchers in the United States report.
"There is increasing use...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.